How to Choose a Pharmaceutical Contract Manufacturer in India

How to Choose a Pharmaceutical Contract Manufacturer in India

• Medical
• October 22, 2026

What Does Pharmaceutical Contract Manufacturing Involve?

Pharmaceutical contract manufacturing involves engaging another organisation to perform agreed manufacturing activities. Depending on the arrangement, these may include formulation development, production, packaging, testing or related technical services.

The scope should identify which activities each party performs and which manufacturing sites are involved.

Activities to Define Include:

• Formulation development and scale-up.
• Technology transfer.
• Raw material procurement.
• Manufacturing and packaging.
• Quality control testing.
• Stability studies.
• Batch review and release responsibilities.
• Regulatory documentation support.
• Storage and dispatch arrangements.

Do not assume that every service is included in a general manufacturing quotation.

Why Manufacturer Selection Matters

The selected manufacturer becomes an important part of your product’s quality and supply arrangements.

Weak documentation, unsuitable equipment or unclear responsibilities can create problems that become expensive to resolve after production begins.

Key Benefits of a Structured Assessment:

1. Clearer Requirements: Manufacturers assess a defined product and market.
2. Better Technical Matching: Facilities are evaluated against the proposed dosage form and process.
3. Stronger Quality Oversight: Evidence supports the approval decision.
4. Comparable Quotations: Prices cover a consistent scope.
5. Clearer Responsibilities: Manufacturing, testing and reporting duties are documented.

Start With a Clear Product Brief

Prepare a controlled product brief before requesting quotations.

A request for “tablet manufacturing” or “injectable manufacturing” does not provide enough information for a meaningful assessment.

Information to Record:

• Active ingredient or ingredients.
• Strength and dosage form.
• Formulation status.
• Intended route of administration.
• Required batch size.
• Forecast demand.
• Container and pack size.
• Intended domestic or export market.
• Available technical documentation.
• Required development or transfer activities.
• Target project milestones.

Distinguish an established formulation ready for transfer from a product requiring development. These projects involve different work, costs and timelines.

Verify the Actual Manufacturer and Manufacturing Site

Confirm the identity of the organisation offering the service and the facility that will perform the work.

A business coordinating an enquiry may use a separate manufacturing partner. Understand that relationship before assessing licences, capabilities or quality records.

Details to Verify:

• Legal name of the contracting organisation.
• Legal name and address of the manufacturing site.
• Applicable manufacturing licences.
• Authorised activities and relevant product permissions.
• Proposed testing and packaging locations.
• Any subcontracted activities.
• Responsible quality and regulatory contacts.

Documents should relate to the proposed site and activities. A certificate for another facility does not establish the suitability of the site handling your product.

Review GMP Compliance and Supporting Evidence

Good Manufacturing Practices help control the processes that affect pharmaceutical quality.

India’s revised Schedule M addresses GMP and requirements for pharmaceutical premises, plant and equipment. Assess the proposed site against applicable current requirements rather than relying on a general statement of compliance. pib.gov.in

Documents and Evidence to Discuss:

• Applicable manufacturing authorisations.
• Relevant GMP certificates and their scope.
• Issuing authority and certificate validity.
• Recent inspection history.
• Significant inspection observations.
• Corrective and preventive action records.
• Relevant site quality documentation.
• Changes affecting regulatory status.

Verify claims such as “WHO-GMP certified” against the actual document, issuing authority, site and covered activities. Do not interpret the phrase as WHO endorsement of every product manufactured there.

Assess Experience With Your Dosage Form

A manufacturer’s experience should match the proposed product and process.

Producing conventional tablets does not automatically establish capability for modified-release products, sterile injections or specialised formulations.

Technical Questions to Ask:

• Has the site manufactured comparable dosage forms?
• Can its equipment accommodate the proposed batch size?
• Are the required processing technologies available?
• What product-specific validation is needed?
• Can the site meet the proposed specifications?
• What technical gaps remain before production?
• Who will manage development and transfer activities?

Ask for relevant evidence that can be shared without compromising another customer’s confidential information.

Review Contamination Control and Facility Suitability

Assess whether the facility can manage the risks associated with the proposed product.

This is particularly important for sterile products, sensitising substances, potent compounds and products requiring specialised containment.

Areas for Technical Review:

• Personnel and material flows.
• Segregation and containment arrangements.
• Cleaning procedures and validation.
• Environmental controls.
• Relevant water and utility systems.
• Equipment suitability.
• Waste handling.
• Product-specific contamination risks.

For sterile products, qualified reviewers should examine the proposed sterilisation or aseptic processing approach and supporting controls.

A general statement that a facility manufactures injections is insufficient to establish suitability for a particular sterile product.

Evaluate the Pharmaceutical Quality System

Certificates provide only part of the assessment. Review how the manufacturer manages quality during routine operations and when problems occur.

Ask the quality team to explain relevant procedures and provide appropriate supporting examples.

Quality System Areas to Review:

• Document control.
• Personnel training.
• Supplier qualification.
• Material receipt and release.
• Deviations and investigations.
• Out-of-specification results.
• Corrective and preventive actions.
• Change control.
• Product quality reviews.
• Complaint handling and recalls.

Focus on how issues are investigated, documented and communicated. A claim that problems never occur provides less useful evidence than a clear, effective investigation process.

Check Testing, Data Integrity and Stability Support

Confirm which laboratory will perform testing and whether it can support the agreed specifications.

A finished-product certificate of analysis should be backed by appropriate methods, records and quality review.

Questions to Clarify:

• Which tests are performed at the manufacturing site?
• Which tests are outsourced?
• Are analytical methods suitable and appropriately validated or verified?
• Is method transfer required?
• How are original records and electronic data retained?
• How are audit trails and access permissions controlled?
• What stability programme supports the proposed product?
• Who reviews unexpected results and trends?

Confirm that stability evidence supports the intended formulation, packaging and storage conditions. Do not assume that data for a different presentation automatically supports your product.

Confirm Destination-Market Requirements

Manufacturing suitability in India and permission to supply another country are separate considerations.

For export projects, the responsible regulatory team should assess the intended market before the manufacturing arrangement is finalised.

Information to Confirm:

• Intended country and supply route.
• Product registration or authorisation requirements.
• Acceptability of the proposed manufacturing site.
• Required technical dossier documents.
• Label and leaflet requirements.
• Stability and packaging requirements.
• Responsibilities for regulatory submissions.
• Access to documents needed throughout the product lifecycle.

Do not assume that an Indian manufacturing licence or GMP certificate provides automatic access to every export market.

Agree on Technology Transfer and Ownership

Where an existing product is transferred, define what information and materials the receiving manufacturer needs.

Where development is required, establish who owns the resulting formulation, methods and project outputs.

Transfer and Ownership Topics Include:

• Formulation and process information.
• Analytical methods.
• Reference standards.
• Equipment differences.
• Trial or engineering batches.
• Validation responsibilities.
• Transfer acceptance criteria.
• Intellectual property and confidentiality.
• Access to records if the relationship ends.

Document these matters before substantial development work begins.

Compare Capacity, Lead Times and Total Costs

Request an itemised quotation based on the same product brief for each shortlisted manufacturer.

Separate development and transfer activities from routine production costs.

Commercial Details to Confirm:

• Minimum order quantity and its unit.
• Proposed batch size.
• Development and transfer fees.
• Validation and testing charges.
• Packaging and artwork costs.
• Stability study costs.
• Raw material lead times.
• Production scheduling assumptions.
• Quality review and release timelines.
• Payment terms.
• Handling of rejected or cancelled batches.

Ask what starts the quoted lead time. It may depend on approved artwork, material availability, completed transfer work and other prerequisites.

Put Quality Responsibilities in Writing

Use a written quality agreement alongside the commercial arrangements.

WHO GMP guidance calls for a written contract covering outsourced activities and clearly defined responsibilities. Outsourcing requires continuing oversight by the contract giver. cdn.who.int

Responsibilities to Define:

• Material and supplier approval.
• Manufacturing and packaging controls.
• Testing and batch review.
• Applicable release decisions.
• Deviation and investigation reporting.
• Change notification and approval.
• Stability monitoring.
• Record retention and access.
• Complaint investigation.
• Recall coordination.
• Audit rights.
• Control of subcontracted activities.

Set communication timelines and escalation contacts, especially for significant quality events.

A Practical Contract Manufacturer Selection Checklist

Assess the Site Before Final Approval

Use qualified personnel to assess the facility and relevant records. The depth of assessment should reflect the product, process and associated risks.

Suggested Assessment Process:

1. Screen Documents: Review the product brief, site information and authorisations.
2. Assess Technical Fit: Identify capability gaps and required development.
3. Review Quality Evidence: Examine relevant procedures and performance records.
4. Conduct an Appropriate Audit: Assess the proposed site and activities.
5. Resolve Findings: Review corrective actions and remaining risks.
6. Finalise Agreements: Complete technical, quality and commercial terms.
7. Authorise Defined Work: Approve the agreed development, transfer or manufacturing stage.
8. Monitor Performance: Review quality events, delivery performance and changes.

A successful sample or trial batch does not replace the wider assessment.

Common Manufacturer Selection Mistakes Buyers Should Avoid

Choosing Only on Price

A low unit price may exclude testing, validation, stability work or packaging activities needed for the project.

Relying on General Certification Claims

Check the site, scope, issuer and validity of supporting documents.

Confusing a Coordinator With the Manufacturer

Identify who manufactures, tests, releases and supplies the product.

Accepting Unclear Timelines

Establish prerequisites and distinguish production time from the full project schedule.

Leaving Quality Duties Undocumented

Agree on investigations, changes, records and recall responsibilities before manufacturing begins.

Assuming Export Eligibility

Assess destination-market requirements for the exact product and site.

Discussing Contract Manufacturing Requirements With Zircon Medtech

Businesses approaching Zircon Medtech should provide a structured product brief and request written clarification of the proposed manufacturing arrangement.

Details to Request Include:

• Zircon Medtech’s role in the project.
• Proposed manufacturer and site.
• Available dosage forms and relevant capabilities.
• Supporting authorisations and quality documents.
• Development or transfer requirements.
• Minimum order quantities.
• Itemised pricing.
• Expected milestones and prerequisites.
• Regulatory documentation support.
• Quality agreement arrangements.

Confirm the scope for each product rather than assuming that one arrangement covers every formulation or market.

Making a Documented Manufacturing Decision

Choosing a pharmaceutical contract manufacturer in India requires evidence of product-specific capability, suitable quality systems and clearly assigned responsibilities.

Begin with a detailed product brief, verify the actual site and involve qualified technical and regulatory reviewers. Resolve assessment findings and finalise written agreements before authorising the relevant work.

Continue monitoring the relationship as products, processes and supply requirements change.